Cypris Therapeutics

About:

Cypris Therapeutics is a chemistry-focused pharmaceutical start-up.

Top Investors: Ichor Life Sciences

Description:

Cypris Therapeutics is a chemistry-focused pharmaceutical start-up that uses proprietary synthetic chemistry and drug development skills to produce next-generation treatments for unmet medical needs.

Total Funding Amount:

$500000

Headquarters Location:

Syracuse, New York, United States

Founded Date:

2024-01-01

Contact Email:

info(AT)cypristx.com

Founders:

Kyle Parella

Number of Employees:

1-10

Last Funding Date:

2024-06-25

IPO Status:

Private

Industries: